Novartis AG
ORGANIC COMPOUNDS
Last updated:
Abstract:
A solid pharmaceutical composition suitable for oral administration, comprising: (a) S 1 P receptor agonist; and (b) a sugar alcohol.
Status:
Application
Type:
Utility
Filling date:
3 Apr 2020
Issue date:
30 Jul 2020